number of downloads : ?
language
eng
Author
Enomoto Hiroyuki Bio-Medicine, Medicines Development Unit, Eli Lilly Japan K.K., Kobe, Japan
Alev Levent Bio-Medicine, Medicines Development Unit, Eli Lilly Japan K.K., Kobe, Japan
Kato Yuki Clinical Development Department, Shionogi & Co., Ltd., Osaka, Japan
Ishihara Hiroyuki Clinical Development Department, Shionogi & Co., Ltd., Osaka, Japan
Tsuji Toshinaga Medical Affairs Department, Shionogi & Co., Ltd., Osaka, Japan
Ochiai Toshimitsu Biostatistics Department, Shionogi & Co., Ltd., Osaka, Japan
Konno Shinichi Department of Orthopaedic Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan
Subject
double-blind; randomized; placebo-controlled trial; duloxetine; osteoarthritis
Journal Title
JOURNAL OF PAIN RESEARCH
Volume
11
Start Page
809
End Page
821
ISSN
1178-7090
Published Date
2018
DOI
PubMed ID
Publisher
DOVE MEDICAL PRESS LTD
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
The authors thank all clinical investigators and patients for their participation in the study. The authors thank Marion Barnett and Nicholas Smith of Edanz Medical Writing for providing medical writing support, which was funded by Shionogi & Co., Ltd. Editing of the final manuscript was provided by Serina Stretton of ProScribe-Envision Pharma Group and funded by Shionogi & Co., Ltd.; This work was supported by Shionogi & Co., Ltd., Eli Lilly Japan K. K., and Eli Lilly and Company. Shionogi & Co., Ltd., Eli Lilly Japan K. K., and Eli Lilly and Company contributed to study design, data analysis, and writing of the manuscript.